These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2909522)

  • 21. Conversion of antithrombin from an inhibitor of thrombin to a substrate with reduced heparin affinity and enhanced conformational stability by binding of a tetradecapeptide corresponding to the P1 to P14 region of the putative reactive bond loop of the inhibitor.
    Björk I; Ylinenjärvi K; Olson ST; Bock PE
    J Biol Chem; 1992 Jan; 267(3):1976-82. PubMed ID: 1730729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structures of five sulfated hexasaccharides prepared from porcine intestinal heparin using bacterial heparinase. Structural variants with apparent biosynthetic precursor-product relationships for the antithrombin III-binding site.
    Tsuda H; Yamada S; Yamane Y; Yoshida K; Hopwood JJ; Sugahara K
    J Biol Chem; 1996 May; 271(18):10495-502. PubMed ID: 8631846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The antithrombin-binding sequence in heparin. Identification of an essential 6-O-sulfate group.
    Lindahl U; Bäckström G; Thunberg L
    J Biol Chem; 1983 Aug; 258(16):9826-30. PubMed ID: 6885772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of Arg46 and Arg47 of antithrombin in heparin binding.
    Arocas V; Bock SC; Olson ST; Björk I
    Biochemistry; 1999 Aug; 38(31):10196-204. PubMed ID: 10433728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism of acceleration of antithrombin-proteinase reactions by low affinity heparin. Role of the antithrombin binding pentasaccharide in heparin rate enhancement.
    Streusand VJ; Björk I; Gettins PG; Petitou M; Olson ST
    J Biol Chem; 1995 Apr; 270(16):9043-51. PubMed ID: 7721817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure of the antithrombin-binding site in heparin.
    Lindahl U; Bäckström G; Höök M; Thunberg L; Fransson LA; Linker A
    Proc Natl Acad Sci U S A; 1979 Jul; 76(7):3198-202. PubMed ID: 226960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contribution of monosaccharide residues in heparin binding to antithrombin III.
    Atha DH; Lormeau JC; Petitou M; Rosenberg RD; Choay J
    Biochemistry; 1985 Nov; 24(23):6723-9. PubMed ID: 4084555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antithrombin conformation and the catalytic role of heparin. I. Does cleavage by thrombin induce structural changes in the heparin-binding region of antithrombin?
    Peterson CB; Blackburn MN
    J Biol Chem; 1987 Jun; 262(16):7552-8. PubMed ID: 3584126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of the basic fibroblast growth factor binding sequence in fibroblast heparan sulfate.
    Turnbull JE; Fernig DG; Ke Y; Wilkinson MC; Gallagher JT
    J Biol Chem; 1992 May; 267(15):10337-41. PubMed ID: 1587820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sequence analysis of heparan sulphate indicates defined location of N-sulphated glucosamine and iduronate 2-sulphate residues proximal to the protein-linkage region.
    Turnbull JE; Gallagher JT
    Biochem J; 1991 Jul; 277 ( Pt 2)(Pt 2):297-303. PubMed ID: 1859357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of heparin and heparan sulfate domains binding to the long splice variant of platelet-derived growth factor A chain.
    Feyzi E; Lustig F; Fager G; Spillmann D; Lindahl U; Salmivirta M
    J Biol Chem; 1997 Feb; 272(9):5518-24. PubMed ID: 9038157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of a reducing-end extension on pentasaccharide binding by antithrombin.
    Belzar KJ; Dafforn TR; Petitou M; Carrell RW; Huntington JA
    J Biol Chem; 2000 Mar; 275(12):8733-41. PubMed ID: 10722716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The signature 3-O-sulfo group of the anticoagulant heparin sequence is critical for heparin binding to antithrombin but is not required for allosteric activation.
    Richard B; Swanson R; Olson ST
    J Biol Chem; 2009 Oct; 284(40):27054-64. PubMed ID: 19661062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antithrombin-binding oligosaccharides: structural diversities in a unique function?
    Guerrini M; Mourier PA; Torri G; Viskov C
    Glycoconj J; 2014 Oct; 31(6-7):409-16. PubMed ID: 25145542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lysine 114 of antithrombin is of crucial importance for the affinity and kinetics of heparin pentasaccharide binding.
    Arocas V; Bock SC; Raja S; Olson ST; Bjork I
    J Biol Chem; 2001 Nov; 276(47):43809-17. PubMed ID: 11567021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of novel sequences containing 3-O-sulfated glucosamine in glomerular basement membrane heparan sulfate and localization of sulfated disaccharides to a peripheral domain.
    Edge AS; Spiro RG
    J Biol Chem; 1990 Sep; 265(26):15874-81. PubMed ID: 2144291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heparin proteoglycans synthesized by mouse mastocytoma contain chondroitin sulphate.
    Lidholt K; Eriksson I; Kjellén L
    Biochem J; 1995 Oct; 311 ( Pt 1)(Pt 1):233-8. PubMed ID: 7575459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased affinity of recombinant antithrombin for heparin due to increased glycosylation.
    Björk I; Ylinenjärvi K; Olson ST; Hermentin P; Conradt HS; Zettlmeissl G
    Biochem J; 1992 Sep; 286 ( Pt 3)(Pt 3):793-800. PubMed ID: 1417738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heterogeneity of rat skin heparin chains with high affinity for antithrombin.
    Horner AA
    Biochem J; 1987 Jun; 244(3):693-8. PubMed ID: 3446185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction of antithrombin with sulfated, low molecular weight lignins: opportunities for potent, selective modulation of antithrombin function.
    Henry BL; Connell J; Liang A; Krishnasamy C; Desai UR
    J Biol Chem; 2009 Jul; 284(31):20897-908. PubMed ID: 19497853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.